|
|
Article: Commercial Insight - Cardiovascular and metabolic market overview Diabetes to the fore as generics hit primary care markets.
- Article from:
- M2 Presswire
- Article date:
- April 16, 2009
CopyrightCOPYRIGHT 2009 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-16 April 2009-www.companiesandmarkets.com: Commercial Insight - Cardiovascular and metabolic market overview Diabetes to the fore as generics hit primary care markets(C)1994-2009 M2 COMMUNICATIONS LTD
RDATE:16042009
-www.companiesandmarkets.com adds new report: Commercial Insight - Cardiovascular and metabolic market overview Diabetes to the fore as generics hit primary care markets
Introduction
Datamonitor expects antidiabetic therapies to emerge as the biggest revenue earner in the cardiovascular and metabolic markets by 2017. A large and diverse development pipeline will provide a number of new blockbuster drugs but ...